共 50 条
- [11] Second-Generation Drug-Eluting Stent Implantation Followed by 6-Versus 12-Month Dual Antiplatelet Therapy The SECURITY Randomized Clinical TrialJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (20) : 2086 - 2097Colombo, AntonioChieffo, AlaideFrasheri, ArianGarbo, RobertoMasotti-Centol, MonicaSalvatella, NeusDominguez, Juan Francisco OteoSteffanon, LuigiTarantini, GiuseppePresbitero, PatriziaMenozzi, AlbertoPucci, EdoardoMauri, JosepaCesana, Bruno MarioGiustino, GennaroSardella, Gennaro
- [12] Clinical Outcomes in Patients With High Bleeding Risk and Bifurcations After Percutaneous Coronary Intervention With Resolute Onyx and 1-Month Dual Antiplatelet TherapyJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (19) : B41 - B42Kirtane, AjayKandzari, DavidLatib, AzeemKedhi, ElvinMehran, RoxanaPrice, MatthewSimon, DanielAbizaid, AlexandreParke, MariaLung, Te-HsinWindecker, StephanStone, Gregg
- [13] Evaluation of Safety of 1-month Dual Antiplatelet Therapy Followed by Prasugrel Monotherapy in Patients Implanted Resolute Zotarolimus-eluting StentJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : S82 - S83Wataru, FujimotoSawada, TakahiroTakaya, TomofumiYasaka, Yoshinori
- [14] Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trialCardiovascular Intervention and Therapeutics, 2021, 36 : 91 - 103Hirotoshi WatanabeTakenori DomeiTakeshi MorimotoMasahiro NatsuakiHiroki ShiomiToshiaki ToyotaMasanobu OhyaSatoru SuwaKensuke TakagiMamoru NanasatoYoshiki HataMasahiro YagiNobuhiro SuematsuTakafumi YokomatsuItaru TakamisawaMasayuki DoiToshiyuki NodaHideki OkayamaYoshitane SeinoTomohisa TadaHiroki SakamotoKiyoshi HibiMitsuru AbeKazuya KawaiKoichi NakaoKenji AndoKengo TanabeYuji IkariKeiichi Igarashi HanaokaYoshihiro MorinoKen KozumaKazushige KadotaYutaka FurukawaYoshihisa NakagawaTakeshi Kimura
- [15] Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk Insight From the STOPDAPT-2 TrialCIRCULATION, 2019, 140 (23) : 1957 - 1959Watanabe, HirotoshiDomei, TakenoriMorimoto, TakeshiNatsuaki, MasahiroShiomi, HirokiToyota, ToshiakiOhya, MasanobuSuwa, SatoruTakagi, KensukeNanasato, MamoruHata, YoshikiYagi, MasahiroSuematsu, NobuhiroYokomatsu, TakafumiTakamisawa, ItaruDoi, MasayukiNoda, ToshiyukiOkayama, HidekiSeino, YoshitaneTada, TomohisaSakamoto, HirokiHibi, KiyoshiAbe, MitsuruKawai, KazuyaNakao, KoichiAndo, KenjiTanabe, KengoIkari, YujiHanaoka, Keiichi IgarashiMorino, YoshihiroKozuma, KenKadota, KazushigeFurukawa, YutakaNakagawa, YoshihisaKimura, Takeshi
- [16] Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndromeCLINICAL CARDIOLOGY, 2017, 40 (10) : 789 - 796Jiang, MinghuanYou, Joyce H. S.
- [17] Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy A Secondary Analysis of the LEADERS FREE Randomized Clinical TrialJAMA CARDIOLOGY, 2020, 5 (08) : 939 - 947Mehran, RoxanaChandrasekhar, JayaUrban, PhilipLang, Irene M.Windhoevel, UteSpaulding, ChristianCopt, SamuelStoll, Hans-PeterMorice, Marie-Claude
- [18] Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trialCARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2021, 36 (01) : 91 - 103Watanabe, HirotoshiDomei, TakenoriMorimoto, TakeshiNatsuaki, MasahiroShiomi, HirokiToyota, ToshiakiOhya, MasanobuSuwa, SatoruTakagi, KensukeNanasato, MamoruHata, YoshikiYagi, MasahiroSuematsu, NobuhiroYokomatsu, TakafumiTakamisawa, ItaruDoi, MasayukiNoda, ToshiyukiOkayama, HidekiSeino, YoshitaneTada, TomohisaSakamoto, HirokiHibi, KiyoshiAbe, MitsuruKawai, KazuyaNakao, KoichiAndo, KenjiTanabe, KengoIkari, YujiHanaoka, Keiichi IgarashiMorino, YoshihiroKozuma, KenKadota, KazushigeFurukawa, YutakaNakagawa, YoshihisaKimura, Takeshi
- [19] Clinical Outcomes According to Lesion Complexity in Patients With High Bleeding Risk Treated With 1-Month Dual Antiplatelet Therapy Following PCI: Analysis From the Onyx ONE Clear StudyJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : B24 - B24Kandzari, DavidKirtane, AjayMehran, RoxanaPrice, MatthewSimon, DanielLatib, AzeemKedhi, ElvinAbizaid, AlexandreWorthley, Stephen G.Zaman, AzfarLee, LilianLung, Te-HsinWindecker, StephanStone, Gregg
- [20] Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear studyCATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 99 (03) : 583 - 592Kandzari, David E.Kirtane, Ajay J.Mehran, RoxanaPrice, Matthew J.Simon, Daniel, ILatib, AzeemKedhi, ElvinAbizaid, AlexandreWorthley, Stephen G.Zaman, AzfarHudec, MartinStoler, RobertChoi, James W.Kanitkar, MihirConradie, AndreTam, Chor-Cheung FrankieWalton, AntonyGruberg, LuisAndo, KenjiLee, Lilian C.Lung, Te-HsinWindecker, StephanStone, Gregg W.